LIBAGYN

LIBAGYN has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €795,636 and a net result of €297,283. Equity is growing by about 23% per year across the filed financial years. Its solvency ranks better than 60% of 20,490 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).